Moody's Ratings (Moody's) has today affirmed National Bank of Fujairah PJSC (NBF) long-term foreign and local currency deposit ratings at Baa1, short-term foreign and local currency deposit ratings at Prime-2 (P-2), Baseline Credit Assessment (BCA) and Adjusted BCA at ba1. The outlook on the bank's ...
Moody's Ratings (Moody's) has assigned a Aaa rating to the proposed $80 million Virginia Housing Development Authority's ("Virginia Housing") Commonwealth Mortgage Bonds 2023 Series E-Non-AMT, Subseries E-2, and a Aaa rating to the proposed $160 million Commonwealth Mortgage Bonds 2024 Series B - Ta...
Moody's Ratings (Moody's) has today affirmed National Bank of Umm Al-Qaiwain (PSC) (NBQ) long-term local and foreign currency deposit ratings at Baa2, short-term local and foreign currency deposit ratings at Prime-2 (P-2), Baseline Credit Assessment (BCA) and Adjusted BCA at ba2. The outlook on the ...
Awilco Drilling Plc: Keppel denied leave to appeal the ruling of the AR2 arbitration tribunal Further to the stock exchange releases of 23 November 2023 and 15 January 2024 from Awilco Drilling PLC ("Awilco Drilling") regarding the termination of the newbuilding contract between Awilco Rig 2 Pte. Ltd. ("AR2") and Keppel FELS Limited ("KFELS") for the construction of a semi-submersible drilling rig, hull number B382. The Company has today received the decision of the High Court refusing Keppel’s application for leave to appeal the award of the AR2 arbitration tribunal. The award is in AR2's...
Moody's Ratings ("Moody's") today affirmed CoStar Group, Inc.'s ("CoStar") Baa3 senior unsecured rating. The outlook remains stable. Governance, CoStar's prudent financial policy in particular, is a key driver of today's action. Moody's believes that the company's financial metrics will remain con...
Moody's Ratings (Moody's) has downgraded Muhlenberg College's (PA) issuer and outstanding debt ratings to A3 from A2. Concurrently, Moody's has assigned an A3 to the $75 million of College Revenue Bonds (Muhlenberg College Project) Series of 2024. The bonds, to be issued through the Lehigh County Ge...
Surface Transforms has announced a Placing and Subscription seeking £6.5m at 1p, combined with an Open Offer for up to £2m (before expenses). Proceeds will be used for working capital for existing operations and to support the manufacturing scale-up. We introduce summary estimates pending the outcome of the entire fundraising event (including the Open Offer) and the full outturn statement for 2023a due in late May. Our base case assumption is for revenue of £17.5m in 2024e (2023a: £8.3m); this c...
Three Directors at Invesco Perpetual UK Smaller Co bought 7,132 shares at between 411p and 412p. The significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ...
Moody's Ratings (Moody's) affirmed Badger Finance, LLC's ("Badger") Caa2 Corporate Family Rating ("CFR") and the Caa2 rating for the senior secured term loan B. Concurrently, Moody's downgraded the Probability of Default Rating ("PDR") to Caa3-PD from Caa2-PD. The capital structure has a $55 million...
Leclanché SA / Schlagwort(e): Nachhaltigkeit Leclanché verbessert Wertangebot mit neuen PFAS-freien und Nioboxid-Zellen und tritt in Testphase mit Schlüsselpartnern ein 01.05.2024 / 20:00 CET/CEST Leclanché verbessert Wertangebot mit neuen PFAS-freien und Nioboxid-Zellen und tritt in Testphase mit Schlüsselpartnern ein Erhöhtes Interesse an der Zelltechnologie von Leclanché seit der Ankündigung von PFAS-freien Elektroden Lieferung von vollständig PFAS-freien Zellen an wichtige Partner zur Validierung in den nächsten Wochen Erhöhte Nachfrage nach Lithium-Ionen-Zel...
Leclanché SA / Mot-clé(s) : Développement durable Leclanché améliore sa proposition de valeur avec de nouvelles cellules sans PFAS et à l'oxyde de niobium, et entre dans une phase de test avec des partenaires clés 01.05.2024 / 20:00 CET/CEST Leclanché améliore sa proposition de valeur avec de nouvelles cellules sans PFAS et à l'oxyde de niobium, et entre dans une phase de test avec des partenaires clés Intérêt accru pour la technologie cellulaire de Leclanché depuis l'annonce des électrodes sans PFAS Livraison de cellules entièrement exemptes de PFAS à des partenaires cl...
Leclanché SA / Key word(s): Sustainability Leclanché Enhances Value Proposition with New PFAS-Free and Niobium Oxide Cells, Enters Testing Phase with Key Partners 01.05.2024 / 20:00 CET/CEST Leclanché Enhances Value Proposition with New PFAS-Free and Niobium Oxide Cells, Enters Testing Phase with Key Partners Increased interest in Leclanché’s cell technology since the announcement of PFAS-free electrodes Delivery of entirely PFAS free cells to key partners for validation to take place in the next weeks Increased demand for next generation niobium oxide anode lithiu...
Brady Corporation Announces Earnings Conference Call MILWAUKEE, May 01, 2024 (GLOBE NEWSWIRE) -- Brady Corporation (NYSE: BRC), will announce its fiscal 2024 third quarter financial results on Wednesday, May 22, 2024. A conference call will be held beginning at 10:30 a.m. Eastern Time (9:30 a.m. Central Time) Wednesday, May 22, 2024. Participants will be able to access the webcast and presentation live and in replay. This call is being webcast by Notified and can be accessed . About BRCBrady Corporation is an international manufacturer and marketer of complete solutions that identif...
Danone acquires Functional Formularies Press release – Paris, May 01, 2024 Danone acquires Functional Formularies Danone announces today it has successfully completed the acquisition of Functional Formularies, a leading whole foods tube feeding business in the US, from Swander Pace Capital. As part of the Renew Danone strategy, this acquisition strengthens Danone’s Medical Nutrition portfolio in the US by further expanding its enteral tube feeding ranges. Juergen Esser, Deputy CEO and CFO, said: “As a global leader in Medical Nutrition, we are delighted to welcome Functional Formularie...
Danone acquiert Functional Formularies Communiqué de presse – Paris, le 1er mai 2024 Danone acquiert Functional Formularies Danone annonce aujourd’hui avoir réalisé l’acquisition de Functional Formularies, leader aux Etats-Unis de l’alimentation par sonde à base d’aliments, auprès de Swander Pace Capital. Dans le cadre de la stratégie Renew Danone, cette acquisition renforce le portefeuille de Danone en Nutrition Médicale aux Etats-Unis, élargissant sa gamme d’alimentation entérale. Juergen Esser, Directeur Général Adjoint et Directeur Financier : « Nous sommes ravis d'accueillir Funct...
Xtract One Closes Full Exercise of Over-Allotment Option for Additional $1.2 M THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) announces that, in connection with its previously announced public offering (the “Offering”), Eight Capital, as lead agent and sole bookrunner, and Echelon Wealth Partners Inc. (together with Ei...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.